Anthrax vaccine ramps up
Md.-based Emergent BioSolutions gets a contract worth up to $107 million to ready its vaccine. Emergent BioSolutions – Anthrax vaccines – Terrorism – Biological and Chemical – Anthrax

Read more on Washington Post